Rosen's Breast Pathology, 4e

931

Unusual Clinical Presentation of Carcinoma

62. McPherson CP, Swenson KK, Jolitz G, et al. Survival of women ages 40–49 years with breast carcinoma according to method of detection. Cancer 1997;79:1923–1932. 63. Lannin DR, Harris RP, Swanson FH, et al. Difficulties in diagnosis of carcinoma of the breast in patients less than fifty years of age. Surg Gynecol Obstet 1993;177:457–462. 64. Vetto JT, Pommier RF, Schmidt WA, et al. Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective. Arch Surg 1996;131:967–974. 65. Rosen PP, Lesser ML, Kinne DW, et al. Breast carcinoma in women 35 years of age or younger. Ann Surg 1984;199:133–142. 66. Rosen PP, Lesser ML, Kinne DW. Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. J Surg Oncol 1985;28:90–96. 67. Schaefer G, Rosen PP, Lesser ML, et al. Breast carcinoma in elderly women: pathology, prognosis, and survival. Pathol Annu 1984;19 (Pt. 1):195–219. 68. Ashkanani F, Eremin O, Heys SD. The management of cancer of the breast in the elderly. Eur J Surg Oncol 1998;24:396–402. 69. Collins LC, Achacoso N, Nekhlyudov L, et al. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol 2009;33:1802–1808. 70. Meyer JS, Bauer WC, Rao BR. Subpopulations of breast carcinoma de­ fined by S-phase fraction, morphology and estrogen receptor content. Lab Invest 1978;39:225–235. 71. Silvestrini R, Daidore MG, Gentili C. Biologic characteristics of breast cancer and their clinical relevance. Commun Res Breast Dis 1981;2:1–40. 72. Gattuso P, Bloom K, Yaremko L, et al. Prognostic predictors of lymph node metastasis in young patients with breast carcinoma. Mod Pathol 1997;10:19A. 73. Walker RA, Lees E, Webb MB, et al. Breast carcinomas occurring in youngwomen ( < 35 years) are different. Br J Cancer 1996;74:1796–1800. 74. Banz-Jansen C, Heinrichs A, Hedderich M, et al. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade? Arch Gynecol Obstet 2013;288:379–383. 75. Dhodapkar MV, Ingle JN, Cha SS, et al. Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen. An analysis of patients entered on four prospective clinical trials. Cancer 1996;77:683–690. 76. Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in ­elderly women. Features of disease presentation, choice of local and systemic treatments compared with younger post menopausal pa­ tients. Cancer 2004;101:1302–1310. 77. Recht A, Connolly JL, Schnitt SJ, et al. The effect of young age on tu­ mor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1998;14:3–10. 78. Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 1990;8:591–598. 79. Fowble BL, Schultz DJ, Overmoyer B, et al. The influence of young age on outcome and early stage breast cancer. Int J Radiat Oncol Biol Phys 1994;30:23–33. 80. Matthews RH, McNeese MD, Montague ED, et al. Prognostic im­ plications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Radiat Oncol Biol Phys 1988;14:659–663. 81. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989;17:719–725. 82. Rose MA, Henderson IC, Gelman R, et al. Premenopausal breast can­ cer patients treated with conservative surgery, radiotherapy and adju­ vant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys 1989;17:711–717. 83. Haffty BG, Fischer D, Rose M, et al. Prognostic factors for local recur­ rence in the conservatively treated breast cancer patient: a cautious interpretation of the data. J Clin Oncol 1991;9:997–1003. 84. Freedman GM, Fowble BL, Hanlon AL, et al. A close or positive mar­ gin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 1998;41:599–605.

85. Chabner E, Nixon A, Gelman R, et al. Family history and treat­ ment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 1998;16:2045–2051. 86. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on out­ come in patients with ductal carcinoma-in-situ treated with breast- conserving therapy. J Clin Oncol 2000;18:296–306. 87. Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer sub­ type approximation, and local recurrence after breast-conserving therapy . J Clin Oncol 2011;29:3885–3891. 88. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971–957. 89. Hughes KS. Lumpectomy plus tamoxifen with or without irradiation in women 70 or older with early breast cancer. ASCO Annual Meet­ ing, June 4–8, 2010, Chicago, IL. Abstract 507. 90. http://homepages.ed.ac.uk/prime/prime2.html, accessed July 2013. 91. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6- NTRK3 gene fusion as a primary event in human secretory breast car­ cinoma. Cancer Cell 2002;2:367–376. 92. Diallo R, Tognon C, Knezevich SR, et al. Secretory carcinoma of the breast: a genetically defined carcinoma entity. Verh Dtsch Ges Pathol 2003;87:193–203. 93. Litton JK, Ready K, Chen H, et al. Earlier age of onset of BRCA mutation-related cancers in subsequent generations. Cancer 2012;118:321–325. 94. Goodwin PJ, Phillips K-A, West DW, et al. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. J Clin Oncol 2012;30:19–26. 95. Heymann S, Delaloge S, Rahal A, et al. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li- Fraumeni syndrome. Radiat Oncol 2010;5:104. Carcinoma in Fibroepithelial Tumors 96. Cheatle GL, Cutler M. Tumours of the breast. Their pathology, symptoms, diagnosis and treatment . London: Edward Arnold & Co, 1931;483–484. 97. Harrington SW, Miller JM. Malignant changes in fibro-adenoma of the mammary gland. Surg Gynecol Obstet 1940;70:615–619. 98. McDivitt RW, Stewart FW, Farrow JH. Breast carcinoma arising in solitary fibroadenomas. Surg Gynecol Obstet 1967;125:572–576. 99. Diaz NM, Palmer JO, McDivitt RW. Carcinoma arising within fibro­ adenomas of the breast. A clinicopathologic study of 105 patients. Am J Clin Pathol 1991;95:614–622. 100. Fondo EY, Rosen PP, Fracchia AA, et al. The problem of carcinoma developing in a fibroadenoma. Recent experience at Memorial Hospi­ tal. Cancer 1979;43:563–567. 101. Ozzello L, Gump FE. The management of patients with carcino­ mas in fibroadenomatous tumors of the breast. Surg Gynecol Obstet 1985;160:99–103. 102. Rosen PP, Urban JA. Coexistent mammary carcinoma and cystosar­ coma phyllodes. Breast 1975;1:9–15. 103. Yoshida Y, Takaoka M, Fukumoto M. Carcinoma arising in fibroad­ enoma. Case report and review of the world literature. J Surg Oncol 1985;29:132–140. 104. Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibro­ adenoma. A review. Arch Pathol Lab Med 1984;108:590–594. 105. Borecky N, Rickard M. Preoperative diagnosis of carcinoma within fibroadenoma on screening mammograms. J Med Imaging Radiat On- col 2008;52:64–67. 106. Tajima S, Kanemaki Y, Kurihara Y, et al. A case of a fibroadenoma coexisting with an invasive lobular carcinoma in the breast. Breast Cancer 2011;18:319–323. 107. Baker KS, Monsees BS, Diaz NM, et al. Carcinoma within fibroadeno­ mas: mammographic features. Radiology 1990;176:371–374. 108. Gupta RK. Fine needle aspiration (FNA) cytology of concurrent breast carcinoma in fibroadenoma. Cytopathology 1995;6:201–203. 109. Psarianos T, Kench JG, Ung OA, et al. Breast carcinoma in a fibro­ adenoma: diagnosis by fine needle aspiration cytology. Pathology 1998;30:419–421.